Brand name: Folotyn
Use in Cancer Treatment
Pralatrexate is to treat the patients with refractory (does not respond to therapy) or recurrent peripheral T-cell lymphoma (come back).
The FDA’s Accelerated Approval Program has authorised this usage. Confirmatory trials must prove that pralatrexate has a therapeutic benefit in these individuals as a condition of approval.
Pralatrexate is also under research for use in the treatment of other cancers.
Detailed scientific definition- Definition from the NCI Drug Dictionary –
Pralatrexate – MedlinePlus Facts
A layman’s overview of key information regarding this medication, which may contain the following:
- Cautions about this medicine
- What is the use and how?
- Whom should you consult before taking it?
- What you should know about it before using it?
- Other drugs that might interact with it
- Possible negative effects
Drugs are frequently under research to see whether they can assist treat or prevent conditions other than those already prevalent. This patient information leaflet covers uses which have been under authorization. Much of the material, though, might also apply to authorized uses that are being investigated.